p16 expression is not associated with human papillomavirus in urinary bladder squamous cell carcinoma
Riley E. Alexander(Indiana University School of Medicine), Liang Cheng(University of North Carolina at Chapel Hill), Gregory T. MacLennan(Case Western Reserve University), Antonio López-Beltrán(Cordoba University), Muhammad T. Idrees(Indiana University School of Medicine), Rodolfo Montironi(Marche Polytechnic University), Yingchuan Hu(Indiana University – Purdue University Indianapolis), John N. Eble(Indiana University School of Medicine), Thomas M. Ulbright(Indiana University Indianapolis), Jennifer B. Kum(Indiana University School of Medicine), David G Grignon(Indiana University – Purdue University Indianapolis), Robert E. Emerson(Indiana University – Purdue University Indianapolis)
Cited by 80
Related Papers
Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine
|Modern Pathology|2017|404
Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
|Cancers|2021|289
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications
|Cells|2020|256
The World Health Organization 2016 classification of testicular non‐germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel
|Histopathology|2016|236
Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs
|Journal of Clinical Investigation|2016|175